Key stats
About KOSEF US BLOCKBUSTER BIOTECH DRUGS PLUS
Expense ratio
0.49%
Home page
Inception date
May 28, 2024
ISIN
KR7483030003
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks95.56%
Health Technology95.56%
Bonds, Cash & Other4.44%
Cash4.44%
Stock breakdown by region
North America100.00%
Latin America0.00%
Europe0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history